Heneghan, Michael A.
Universidade Federal do Rio Grande · Universidade Federal do Rio Grande do Sul · University of Miami · Ege University · Hospital de Clínicas de Porto Alegre · Azienda Ospedaliero-Universitaria di Modena · King's College Hospital NHS Foundation Trust · Liver Institute Northwest · King's College Hospital · University of California Davis Medical Center · University of Milano-Bicocca · University of California, Davis
17 papers on CoChatORCID 0000-0002-5441-9064
Most cited papers
- Verified
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis
The UK PBC Consortium, Mells, G. F., The Wellcome Trust Case Control Consortium 3, Floyd, J. A. B., Morley, K. I., Cordell, H. J., Franklin, C. S., Shin, S.-Y., Heneghan, M. A., Neuberger, J. M., et al. (2011) · Nature Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 464
- Verified
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic Acid
Carbone, M., Mells, G. F., Pells, G., Dawwas, M. F., Newton, J. L., Heneghan, M. A., Neuberger, J. M., Day, D. B., Ducker, S. J., Sandford, R. N., et al. (2013) · Gastroenterology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 386
- Verified
Liver disease in pregnancy
Joshi, D., James, A., Quaglia, A., Westbrook, R. H., & Heneghan, M. A. (2010) · The Lancet
Pregnancy and preeclampsia studiesLiver Diseases and Immunity
Cited by 385
- Verified
The UK‐PBC risk scores: Derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis
Carbone, M., Sharp, S. J., Flack, S., Paximadas, D., Spiess, K., Adgey, C., Griffiths, L., Lim, R., Trembling, P., Williamson, K., et al. (2016) · Hepatology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 354
- Verified
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
Kowdley, K. V., Bowlus, C. L., Levy, C., Akarca, U. S., Alvares-da-Silva, M. R., Andreone, P., Arrese, M., Corpechot, C., Francque, S. M., Heneghan, M. A., et al. (2024) · New England Journal of Medicine
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 314
- Verified
Patients With Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK
Bernsmeier, C., Pop, O. T., Singanayagam, A., Triantafyllou, E., Patel, V. C., Weston, C. J., Curbishley, S., Sadiq, F., Vergis, N., Khamri, W., et al. (2015) · Gastroenterology
Liver Disease and TransplantationLiver physiology and pathology
Cited by 287
- Verified
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
Cordell, H. J., Han, Y., Mells, G. F., Li, Y., Hirschfield, G. M., Greene, C. S., Xie, G., Juran, B. D., Zhu, D., Qian, D. C., et al. (2015) · Nature Communications
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 287
- Verified
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis
The UK Primary Biliary Cirrhosis (PBC) Consortium, Liu, J. Z., The Wellcome Trust Case Control Consortium 3, Almarri, M. A., Gaffney, D. J., Mells, G. F., Jostins, L., Cordell, H. J., Ducker, S. J., Day, D. B., et al. (2012) · Nature Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 274
- Verified
Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study
Mells, G. F., Pells, G., Newton, J. L., Bathgate, A. J., Burroughs, A. K., Heneghan, M. A., Neuberger, J. M., Day, D. B., Ducker, S. J., Sandford, R. N., et al. (2013) · Hepatology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 227
- Verified
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA
Schattenberg, J. M., Pares, A., Kowdley, K. V., Heneghan, M. A., Caldwell, S., Pratt, D., Bonder, A., Hirschfield, G. M., Levy, C., Vierling, J., et al. (2021) · Journal of Hepatology
Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms
Cited by 191
- Verified
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
Cordell, H. J., Fryett, J. J., Ueno, K., Darlay, R., Aiba, Y., Hitomi, Y., Kawashima, M., Nishida, N., Khor, S.-S., Gervais, O., et al. (2021) · Journal of Hepatology
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 182
- Verified
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
Hirschfield, G. M., Shiffman, M. L., Gulamhusein, A., Kowdley, K. V., Vierling, J. M., Levy, C., Kremer, A. E., Zigmond, E., Andreone, P., Gordon, S. C., et al. (2023) · Hepatology
Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms
Cited by 127
- Verified
The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis
Joshi, D., Bjarnason, I., Belgaumkar, A., O'Grady, J., Suddle, A., Heneghan, M. A., Aluvihare, V., Rela, M., Heaton, N., & Agarwal, K. (2013) · Liver International
Liver Diseases and ImmunityInflammatory Bowel Disease
Cited by 99
- Verified
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis
Asselta, R., Paraboschi, E. M., Gerussi, A., Cordell, H. J., Mells, G. F., Sandford, R. N., Jones, D. E., Nakamura, M., Ueno, K., Hitomi, Y., et al. (2021) · Gastroenterology
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 55
- Verified
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry
Berenguer, M., Di Maira, T., Baumann, U., Mirza, D. F., Heneghan, M. A., Klempnauer, J. L., Bennet, W., Ericzon, B.-G., Line, P.-D., Lodge, P. A., et al. (2021) · Transplantation
Liver Diseases and ImmunityOrgan Transplantation Techniques and Outcomes
Cited by 32
- Verified
Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery
Abbas, N., Smith, R., Flack, S., Bains, V., Aspinall, R. J., Jones, R. L., Burke, L., Thorburn, D., Heneghan, M., Yeoman, A., et al. (2024) · JHEP Reports
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 31
- Verified
P1198 : Histological stage is relevant for risk-stratification in primary biliary cirrhosis
Carbone, M., Sharp, S. J., Heneghan, M. A., Neuberger, J. M., Hirschfield, G. M., Burroughs, A. K., Thorburn, D., Bathgate, A., Aldersley, M., Adgey, C., et al. (2015) · Journal of Hepatology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free